Institutional Ownership
Connect Biopharma Hldgs Ltd
CUSIP G23549101SHSQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
21.5%
Max % of class reported
Institutional Holders
40
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Nov 26, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 26, 2025 | Panacea Innovation Limited | 13D/A | 21.5% | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 5.39M | $13.12M |
| 2 | Boothbay Fund Management, LLC | 1.23M | $3.23M |
| 3 | 683 Capital Management, LLC | 900.0K | $2.36M |
| 4 | Perceptive Advisors LLC | 792.7K | $2.08M |
| 5 | Adar1 Capital Management, LLC | 742.4K | $1.95M |
| 6 | Richmond Brothers, Inc. | 476.6K | $1.25M |
| 7 | Millennium Management LLC | 474.6K | $1.24M |
| 8 | Bml Capital Management, LLC | 408.9K | $1.07M |
| 9 | Knott David M Jr | 387.8K | $1.02M |
| 10 | Stonepine Capital Management, LLC | 310.0K | $812.2K |